Sitemap
-
-
-
-
2023CPHI Barcelona |
Gather together for a new chapter |
Gather strength forge ahead|Jiangsu Runan Pharmaceutical Co.,LTD annual meeting &commendation meeting |
2024CPHI Japan |
Special practical drill for gas leakage accidents in the logistics department of the company in 2024 |
2023API Exhibition |
Speech at the Advanced Experience Exchange Conference of Jiangsu Runan Pharmaceutical on Enterprise Safety Production in Industrial Parks |
Comprehensive practical training for production safety accidents in 2023 |
Notice of Approval for Clinical Trials of Class 1 Innovative Drugs by Jiangsu Zhengda Qingjiang Pharmaceutical Co., Ltd |
Jiangsu Run'an Pharmaceutical Co., Ltd. Safety Production Month Activity Summary, Evaluation, Reward and Commendation Notice |
Jiangsu Runan Pharmaceutical welcomes GMP inspection |
Strengthen intellectual property protection and create an innovative highland |
Chen Zhichang, Secretary of the Municipal Party Committee, conducted research on the construction of the new factory area of Zhengda Qingjiang Pharmaceutical |
Announcement of Jiangsu Run'an Pharmaceutical Co., Ltd. before the 2023 Clean Production Audit |
Sodium nitroprusside and urapidil, both antihypertensive drugs, have different contraindications and adverse reactions! |
Pharmacological characteristics of dexmedetomidine and its application in postoperative delirium in elderly patients |
Who is more effective, Elamod or Methotrexate
-
-
-
-